Patents
Sitemap › G01 - Measuring; Testing › G01N - Investigating or analysing materials by determining their chemical or physical properties › G01N 33 - Investigating or analysing materials by specific methods not covered by groups
Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632)
10/2008
10/30/2008WO2007015886A8 Phosphorylated protein markers of gleevec-resistant chronic myelogenous leukemia
10/30/2008WO2006128933A3 Miniature device for extraction with pressurised liquids
10/30/2008WO2005019793A3 Sensor platform using a horizontally oriented nanotube element
10/30/2008WO2005017110A3 Engineered proteases for affinity purification and processing of fusion proteins
10/30/2008US20080270439 Method for Identifying Sub-Sequences of Interest in a Sequence
10/30/2008US20080270362 Search scheduling apparatus, program and recording medium having the same program recorded therein
10/30/2008US20080270259 Method of maintaining product status using regionally coded interface
10/30/2008US20080270041 System and method for broad-based multiple sclerosis association gene transcript test
10/30/2008US20080270039 Method and device for predicting physiological values
10/30/2008US20080270036 Systems and methods facilitating auxiliary analysis of data from implanted medical devices
10/30/2008US20080269585 System for determining insulin dose using carbohydrate to insulin ratio and insulin sensitivity factor
10/30/2008US20080269475 Sorbent for Nucleic Acids, Comprising Acid-Activated Layer Silicate
10/30/2008US20080269344 respiratory diseases such as asthma, chronic obstructive pulmonary disease, bronchitis; useful in the treatment of nervous system injury and premature labor; 1-{2-[N-2-(4-hydroxy-3-formylaminophenyl)-2-(RS) hydroxyethyl]aminoethyl}-4-[N-(2-phenyl-2-(RS)-hydroxyethyl)amino]phenyl; milveterol
10/30/2008US20080269305 R)-N-{2-Butyl-3-[2'-(2H-tetrazol-5-yl)biphenyl-4-ylmethyl]-3H-imidazol-4-ylmethyl}-2-(2-hydroxycarbamoyl-3-phenyl-propionylamino)succinamic Acid; AT1 receptor antagonist and neprilysin (NEP) enzyme inhibition activity; hypertension, heart failure
10/30/2008US20080269258 Riboswitches, Structure-Based Compound Design with Riboswitches, and Methods and Compositions for Use of and with Riboswitches
10/30/2008US20080269224 Substituted Triazines as Prion Protein Ligands and Their Use to Detect or Remove Prions
10/30/2008US20080269155 Remedy or preventive for kidney disease and method of diagnosing kidney disease
10/30/2008US20080269152 Nucleic acid binding oligonucleotides
10/30/2008US20080269147 Used in targeting specific mRNAs for degradation in mammalian cells where use of long dsRNAs to elicit RNAi is usually not practical, presumably because of the deleterious effects of the interferon response; autoimmune disease; tumor-associated gene
10/30/2008US20080269123 Using modulator of tumor necrosis factor (TNF) pathway such as infliximab, simvastatin; drug screening
10/30/2008US20080269118 Identifying molecule suitable for treatment, prophylaxis or alleviation of a Gpr100 associated disease, in particular diabetes and obesity, by determining whether candidate molecule is an agonist or antagonist of Gpr100 polypeptide, in which Gpr100 polypeptide comprises specific amino acid sequence
10/30/2008US20080269115 Immunogenic Sars Domain
10/30/2008US20080269103 Diagnostic and Therapeutic Use of the Kcne4 Gene and Protein for Alzheimer's Disease
10/30/2008US20080269088 non-acidic, sulfur-containing, phosphorus-containing compound of the formula Such a compound may exhibit improved antiwear performance and thermal stability in lubricating compositions.
10/30/2008US20080269065 Conformationally Constrained Analytical Probes
10/30/2008US20080269064 Method and Kit for Detecting Components in a Sample
10/30/2008US20080268552 Carboxylated latex particles
10/30/2008US20080268551 System and Method for Biological Assays
10/30/2008US20080268550 Modifying silicon wafer solid support to facilitate attachment of functional groups; soft lithography; portable, in-situ; military applications, point-of-care monitoring of drug levels
10/30/2008US20080268547 Systems and Methods for Indicating Oxidation of Consumer Products
10/30/2008US20080268546 Detection of dna hybridization on surfaces
10/30/2008US20080268545 Using magnetism to separate metal particles comprising oligonucleotides hybridized to immobilized DNA probes
10/30/2008US20080268544 Hydrodynamic Isolation Method and Apparatus
10/30/2008US20080268536 Humanized Anti-CCR2 Antibodies and Methods of Use Therefor
10/30/2008US20080268509 Methods of labeling polynucleotides with energy transfer dyes
10/30/2008US20080268495 Preparing Biological Samples for Analysis
10/30/2008US20080268491 Instruments for direct detection of free metals in fluids and methods to diagnose metal-related diseases and determine pharmacologic dosing regimens
10/30/2008US20080268489 Therapeutic polypeptide for use in treatment of heart, hypothermic and cardiovascular disorders
10/30/2008US20080268484 Using thrombin-antithrombin III complex as tool in identifying modulators of glypican-3 expression; treating arteriosclerosis
10/30/2008US20080268482 Colorimetric analysis; kits
10/30/2008US20080268481 Sensitive Magnetic Catch Assay By Building a Strong Binding Couple
10/30/2008US20080268480 Using b-cell activating factor (BAFF) concentration as evaluative tool in diagnosing liver, autoimmune, liver and blood disorder
10/30/2008US20080268479 Using concentration of low molecular weight globulin as evaluative tool in diagnosis/prognosis of autoimmune disorders
10/30/2008US20080268478 Use of Eotaxin as a Diagnostic Indicator For Atherosclerosis and Vascular Inflammation
10/30/2008US20080268477 Advanced glycation endproduct (AGE); 3,4-dideoxyglucosone-3-ene (3,4-DGE); immunization
10/30/2008US20080268476 Nectin 4 (N4) as a Marker for Cancer Prognosis
10/30/2008US20080268475 Transgenic saccharomyces comprising orphan receptors for use in monitor drug binding affinities; drug screening
10/30/2008US20080268474 Prion protein ligands and methods of use
10/30/2008US20080268473 Using metalloprotease concentration as evaluative indicator of cell proliferative disorders
10/30/2008US20080268472 High throughput assay systems and methods for identifying agents that alter expression of cellular proteins
10/30/2008US20080268471 For use in foods, beverages, and drugs
10/30/2008US20080268470 Methods of selecting cell clones
10/30/2008US20080268469 Systems and Methods for Analyzing a Particulate
10/30/2008US20080268468 Alkynyl sugar analogs for the labeling and visualization of glycoconjugates in cells
10/30/2008US20080268467 Using chromodomain ( MRG15 protein) repressor complex to identify modulators for treatment and prevention of viral, cardiovascular, nervous system, autoimmune and liver disorders
10/30/2008US20080268466 Using presence of adhesin protein in vaginal swab as evaluative indicator of parasitic infection of urogenital organs
10/30/2008US20080268465 Process and Kit for Determining Binding Parameters of Bioaffinity Binding Reactions
10/30/2008US20080268464 Apparatus for identifying modulators of papain activity; drug screening; monitoring drug efficacy
10/30/2008US20080268463 Using concentration of cortitropin releasing hormone (CRH), dehydroepiandrosterone (DHEA), neuropeptide Y (NPY) and/or galanin as evaluative tool in diagnosis/prognosis of urogenital pain
10/30/2008US20080268462 Derivatives containing oxazole, pyrazole, thiazole, nitroaryl compound, benzofurazan, triterpene, urea, thiourea, rotenoid, coumarin or cyclolignan such as 4-(2-hydroxyphenyl)-1H-benzo[b][1,4]diazepine-2(3H)-one; multiplexed diagnostic assay for multiple targets in sample; antibodies; kits
10/30/2008US20080268461 Method of Measuring Cholesterol in Remnant-Like Lipoproteins
10/30/2008US20080268460 Assays to Identify Irreversibly Binding Inhibitors of Receptor Tyrosine Kinases
10/30/2008US20080268459 Immunoglobulin for use in diagnosis and treatment of cell proliferative disorders; antitumor agents; immunodiagnostics
10/30/2008US20080268455 Detection of nuceic acids by multiple sequential invasive cleavages
10/30/2008US20080268450 Using porous ligand conjugated microparticle probe to screen for preferential nucleic acids, proteins, peptides, metal ions, haptens, drugs, metabolites, pesticides and/or pollutants
10/30/2008US20080268445 Rodent model comprising mutation in adenine nucleotide translocator (ANT) gene for use in identifying modulators for prevention and treatment of cardiac disorders
10/30/2008US20080268439 Using cells expressing potassium channel (SK2) proteins as tool in identifying modulator for prevention and treatment of neuropathic pain and nervous system disorders
10/30/2008US20080268435 Using psoriasin gene expression profile as evaluative tool in determining functionality of breast cancer gene
10/30/2008US20080268428 Chromosome 5 Genetic Variants Related to Dyslexia
10/30/2008US20080268427 Using presence of viral gp48 polypeptide in follicles of cattle as diagnostic indicator of viral disease; veterinary medicine
10/30/2008US20080268424 Glut-1 as a Receptor for Htlv Envelopes and its Uses
10/30/2008US20080268423 Using immobilized envelope protein domain as tools to identify immunoglobulins generate in response to tick borne encephalitis viral and/or west nile viral infections
10/30/2008US20080268420 Using b-cells as targeting tools for recovery of preferential tumor antigen specific immunoglobulins; tissue targeted therapy; antitumor agents; diagnosing cell proliferative disorders
10/30/2008US20080268287 Method of Converting Water-Soluble Active Proteins Into Hydrophobic Active Proteins, the Use of the Same for the Preparation of Monomolecular Layers of Oriented Active Proteins, and Devices Comprising the Same
10/30/2008US20080268111 provides the consumer of the food substance an opportunity to reject or discard the substance prior to digestion, thus promoting good health and avoiding potential ingestion of relatively high concentrations of carcinogenic potent acrylamides
10/30/2008US20080268109 Low glycemic sweetener compositions
10/30/2008US20080268067 inhibiting a Cav3 calcium channel in a cell using a C2-C10 alkyl alcohol;
10/30/2008US20080267999 Neoepitope detection of disease using protein arrays
10/30/2008US20080267988 Myelin specific IgE unencumbered by corresponding blocking antibodies as a causative factor in multiple sclerosis
10/30/2008US20080267987 Major histocompatibility complex polypeptide for use in targeting, detecting and purifying antigen-specific T-cells; for treatment and prevention of inflammatory, arthritic and autoimmune disease
10/30/2008US20080267982 Generating E7 oncoprotein specific immunoglobulin for use as evaluative tool in diagnosing urogenital cell proliferative, brain and prion disorders
10/30/2008US20080267975 Using lymphocyte profiles comprising aberrant transmembrane receptor tyrosine kinase (Mer) expression as evaluative tool in screening for blood clotting and/or cell proliferative disorders
10/30/2008US20080267973 Diagnosis and Treatment of Siglec-6 Associated Diseases
10/30/2008US20080267967 Modulation of cd200 receptors
10/30/2008US20080267965 Use of Bcma as an Immunoregulatory Agent
10/30/2008US20080267958 Lymphatic endothelial glycoprotein for use as tool in identifying modulators for prevention and treatment of inflammation and cell proliferative disorders
10/30/2008US20080267955 Frizzled 9 as tumor marker
10/30/2008US20080267952 Using concentration of immunoglobulins specific oxidized forms of amyloid beta in blood as evalauative indicator of alzheimer's disease
10/30/2008US20080267948 Croos-B Structure Binding Compounds
10/30/2008US20080267936 Treatment of trauma-hemorrhage with short oligopeptides
10/30/2008US20080267929 Use of stem cells to generate inner ear cells
10/30/2008US20080267922 Slitrks as markers for stem and progenitor cells and methods of use thereof
10/30/2008US20080267910 Nucleotide sequences coding interleukin-21/22 for use in identifying modulators for prevention and treatment of viral infection and cell proliferative disorders
10/30/2008US20080267908 Using alteration in interleukin-32 binding to proteinase-3 to identify compounds which maybe useful in treatment of inflammatory disorders
10/30/2008US20080267882 Multimeric RGD (arginine-glycine-aspartic acid (Arg-Gly-Asp)) peptide; positron emission tomography; angiogenesis; kits
10/30/2008US20080267880 Via uptake of fluorescent marker dye on microtiter plates; kits
10/30/2008US20080267877 Administering carrier molecule such as albumin conjugated to mannose-6-phosphate; particularly targeting Hepatic Stellate Cells (HSC); glomeruloscherosis, interstitial fibrosis, lung fibrosis, atherosclerosis, Crohn's disease, colitis ulcerosa, glomerulonephritis and sepsis; diagnosis
10/30/2008US20080267872 The 98P4B6 gene, its fragment, its encoded protein, variants , or a fragment, can be used to elicit a humoral or cellular immune response; antibodies or T cells reactive with 98P4B6 can be used in active or passive immunization
10/30/2008US20080267871 Cardioinhibitory/ Antihypertensive Novel Endogenous Physiologically Active Peptide
10/30/2008US20080267866 Cross-bridged tetraamine macrocycles complexed with transition metal ions, radioactive metal species, fluorescent tag; as CXCR4 co-receptor antagonist is a dosage form for treatment of HIV; radiopharmaceutical for imaging chemokine receptors; drug screening assays for chemokine receptor binding
1 ... 1360 1361 1362 1363 1364 1365 1366 1367 1368 1369 1370 1371 1372 1373 1374 1375 1376 1377 1378 1379 1380 ... 3937